205 related articles for article (PubMed ID: 25066288)
1. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal.
Durack A; Matin RN
Br J Dermatol; 2014 Jul; 171(1):10-3. PubMed ID: 25066288
[No Abstract] [Full Text] [Related]
2. Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'.
Rosén K; Maurer M; Hsieh H; Saini S; Grattan C; Gimenéz-Arnau A; Agarwal S; Doyle R; Canvin J; Kaplan A; Casale T
Br J Dermatol; 2014 Jul; 171(1):15-6. PubMed ID: 25066290
[No Abstract] [Full Text] [Related]
3. Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Sabroe RA
Br J Dermatol; 2014 Jul; 171(1):13-5. PubMed ID: 25066289
[No Abstract] [Full Text] [Related]
4. Omalizumab for chronic urticaria.
Altman MC; Naimi DR
N Engl J Med; 2013 Jun; 368(26):2528-30. PubMed ID: 23802532
[No Abstract] [Full Text] [Related]
5. Omalizumab for chronic urticaria.
Benelli E; Ventura A
N Engl J Med; 2013 Jun; 368(26):2528. PubMed ID: 23802531
[No Abstract] [Full Text] [Related]
6. Omalizumab for chronic urticaria.
Wu K; Long H
N Engl J Med; 2013 Jun; 368(26):2527-8. PubMed ID: 23802530
[No Abstract] [Full Text] [Related]
7. Omalizumab for chronic urticaria.
Maurer M; Rosén K; Hsieh HJ
N Engl J Med; 2013 Jun; 368(26):2530. PubMed ID: 23802529
[No Abstract] [Full Text] [Related]
8. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Maurer M; Rosén K; Hsieh HJ; Saini S; Grattan C; Gimenéz-Arnau A; Agarwal S; Doyle R; Canvin J; Kaplan A; Casale T
N Engl J Med; 2013 Mar; 368(10):924-35. PubMed ID: 23432142
[TBL] [Abstract][Full Text] [Related]
9. Extraordinary response to omalizumab in a child with severe chronic urticaria.
Asero R; Casalone R; Iemoli E
Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):41-2. PubMed ID: 24702874
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab (Xolair) for the treatment of chronic idiopathic urticarial.
Scheinfeld N
Skinmed; 2014; 12(5):294-7. PubMed ID: 25632648
[No Abstract] [Full Text] [Related]
11. Omalizumab for chronic urticaria.
Casale TB
J Allergy Clin Immunol Pract; 2014; 2(1):118-9. PubMed ID: 24565785
[No Abstract] [Full Text] [Related]
12. Chronic urticaria: omalizumab and review of therapeutic options.
Bergstrom KG
J Drugs Dermatol; 2013 Jun; 12(6):715-6. PubMed ID: 23839196
[TBL] [Abstract][Full Text] [Related]
13. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
Lang DM
Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
[No Abstract] [Full Text] [Related]
14. Effects of omalizumab in a patient with three types of chronic urticaria.
Vieira Dos Santos R; Locks Bidese B; Rabello de Souza J; Maurer M
Br J Dermatol; 2014 Feb; 170(2):469-71. PubMed ID: 24102388
[No Abstract] [Full Text] [Related]
15. Omalizumab in chronic urticaria.
Metz M; Maurer M
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria.
Mathias SD; Crosby RD; Zazzali JL; Maurer M; Saini SS
Ann Allergy Asthma Immunol; 2012 Jan; 108(1):20-24. PubMed ID: 22192960
[TBL] [Abstract][Full Text] [Related]
17. JID VisualDx Quiz: January 2015.
Shabbir A; Kirsner RS
J Invest Dermatol; 2015 Jan; 135(1):1-2. PubMed ID: 25501381
[No Abstract] [Full Text] [Related]
18. Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation?
Tontini C; Marinangeli L; Cognigni M; Bilò MB; Antonicelli L
Ann Allergy Asthma Immunol; 2015 Aug; 115(2):147-8. PubMed ID: 26048249
[No Abstract] [Full Text] [Related]
19. Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis.
Kai AC; Flohr C; Grattan CE
Clin Exp Dermatol; 2014 Jul; 39(5):651-2. PubMed ID: 24758481
[No Abstract] [Full Text] [Related]
20. Omalizumab for the treatment of chronic urticaria.
Zuberbier T; Maurer M
Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
